Scientist
Biotechnologies Research · 2024-09-13
Proposed Endeavor
The petitioner proposes to utilize genetic engineering tools to enhance the regenerative capabilities of cardiac progenitor cells (CSCs) to improve the treatment of cardiovascular diseases. Specifically, the research will focus on using CSCs to enhance their secretome using lipid nanoparticles to deliver transcription factor encoding mRNA.
Framework Evaluation
0 of 3 criteria metThe Director concluded this prong was not met due to conflation of merit and importance, and an overly restrictive view of private sector contributions, which the AAO found to be an insufficient analysis.
The Director concluded this prong was not met, failing to clearly analyze the evidence against the enumerated factors and making statements inconsistent with the record, leading to an insufficient analysis by the AAO.
The Director concluded this prong was not met but did not discuss or analyze the evidence in relation to the specific factors for this prong, which the AAO deemed a deficiency requiring remand.
Why This Petition Was Remanded
Evidence
Similar Cases
Research Scientist
Biotechnology
Scientist
Biotechnology
Postdoctoral Researcher
Biotechnology
Scientist
Biotechnology · India
Frequently Asked Questions
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2024-09-13.
Browse all casesAt a Glance
EB-2 (NIW) Case Data
Scraped Case Data
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist